Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest Expenses (2020 - 2025)

Treace Medical Concepts' Interest Expenses history spans 6 years, with the latest figure at $1.3 million for Q4 2025.

  • For Q4 2025, Interest Expenses rose 2.74% year-over-year to $1.3 million; the TTM value through Dec 2025 reached $5.3 million, up 1.22%, while the annual FY2025 figure was $5.3 million, 1.22% up from the prior year.
  • Interest Expenses reached $1.3 million in Q4 2025 per TMCI's latest filing, up from $1.3 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $1.3 million in Q4 2025 to a low of $946000.0 in Q2 2022.
  • Average Interest Expenses over 5 years is $1.2 million, with a median of $1.3 million recorded in 2023.
  • Peak YoY movement for Interest Expenses: skyrocketed 133.79% in 2021, then fell 8.86% in 2022.
  • A 5-year view of Interest Expenses shows it stood at $1.0 million in 2021, then grew by 27.53% to $1.3 million in 2022, then dropped by 0.53% to $1.3 million in 2023, then grew by 0.77% to $1.3 million in 2024, then grew by 2.74% to $1.3 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Interest Expenses are $1.3 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025).